JP2008511841A - 自動較正センサの製造方法 - Google Patents
自動較正センサの製造方法 Download PDFInfo
- Publication number
- JP2008511841A JP2008511841A JP2007530391A JP2007530391A JP2008511841A JP 2008511841 A JP2008511841 A JP 2008511841A JP 2007530391 A JP2007530391 A JP 2007530391A JP 2007530391 A JP2007530391 A JP 2007530391A JP 2008511841 A JP2008511841 A JP 2008511841A
- Authority
- JP
- Japan
- Prior art keywords
- sensor
- wireless device
- reagent
- calibration
- electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 108
- 239000012530 fluid Substances 0.000 claims abstract description 38
- 239000012491 analyte Substances 0.000 claims abstract description 32
- 230000008569 process Effects 0.000 claims abstract description 32
- 230000008859 change Effects 0.000 claims abstract description 16
- 239000000126 substance Substances 0.000 claims abstract description 13
- 230000001681 protective effect Effects 0.000 claims abstract description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 72
- 239000008103 glucose Substances 0.000 claims description 72
- 239000003153 chemical reaction reagent Substances 0.000 claims description 71
- 239000000758 substrate Substances 0.000 claims description 53
- 238000000151 deposition Methods 0.000 claims description 41
- 238000007639 printing Methods 0.000 claims description 30
- 230000008021 deposition Effects 0.000 claims description 23
- 238000007650 screen-printing Methods 0.000 claims description 10
- 238000004891 communication Methods 0.000 claims description 8
- 238000010924 continuous production Methods 0.000 claims description 8
- 239000002243 precursor Substances 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 7
- 108010015776 Glucose oxidase Proteins 0.000 claims description 6
- 239000004366 Glucose oxidase Substances 0.000 claims description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 229940116332 glucose oxidase Drugs 0.000 claims description 6
- 235000019420 glucose oxidase Nutrition 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000000090 biomarker Substances 0.000 claims description 4
- 238000005520 cutting process Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 4
- 239000005556 hormone Substances 0.000 claims description 4
- 229940088597 hormone Drugs 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 230000005855 radiation Effects 0.000 claims description 4
- 238000001228 spectrum Methods 0.000 claims description 4
- -1 therapeutic drugs Substances 0.000 claims description 4
- NEGFNJRAUMCZMY-UHFFFAOYSA-N 3-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=CC(C(O)=O)=C1 NEGFNJRAUMCZMY-UHFFFAOYSA-N 0.000 claims description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 230000005611 electricity Effects 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 3
- 238000000695 excitation spectrum Methods 0.000 claims description 3
- 230000005281 excited state Effects 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- 239000002207 metabolite Substances 0.000 claims description 3
- 238000010791 quenching Methods 0.000 claims description 3
- 230000000171 quenching effect Effects 0.000 claims description 3
- 239000003237 recreational drug Substances 0.000 claims description 3
- 238000002834 transmittance Methods 0.000 claims description 3
- 102000001554 Hemoglobins Human genes 0.000 claims description 2
- 108010054147 Hemoglobins Proteins 0.000 claims description 2
- 230000009102 absorption Effects 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 238000007607 die coating method Methods 0.000 claims description 2
- 238000007647 flexography Methods 0.000 claims description 2
- 238000007646 gravure printing Methods 0.000 claims description 2
- 238000007641 inkjet printing Methods 0.000 claims description 2
- 238000010330 laser marking Methods 0.000 claims description 2
- 238000001459 lithography Methods 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 230000010287 polarization Effects 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 3
- DWKDMDLAHXJIMH-UHFFFAOYSA-N 1-(3-chloro-4-methylphenyl)-N-(2-oxo-1-propyl-3,4-dihydroquinolin-6-yl)methanesulfonamide Chemical compound ClC1=CC(CS(=O)(=O)NC2=CC=C3N(CCC)C(=O)CCC3=C2)=CC=C1C DWKDMDLAHXJIMH-UHFFFAOYSA-N 0.000 claims 1
- 238000006555 catalytic reaction Methods 0.000 claims 1
- 150000007857 hydrazones Chemical class 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- GNURASXBKKXAOM-JGWLITMVSA-N oxido-[(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexylidene]oxidanium Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=[O+][O-] GNURASXBKKXAOM-JGWLITMVSA-N 0.000 claims 1
- 239000012041 precatalyst Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 229940126585 therapeutic drug Drugs 0.000 claims 1
- 230000004044 response Effects 0.000 abstract description 10
- 238000012360 testing method Methods 0.000 description 107
- 239000010410 layer Substances 0.000 description 75
- 239000008280 blood Substances 0.000 description 66
- 210000004369 blood Anatomy 0.000 description 66
- 206010012601 diabetes mellitus Diseases 0.000 description 28
- 239000004020 conductor Substances 0.000 description 20
- 238000004806 packaging method and process Methods 0.000 description 15
- 239000000853 adhesive Substances 0.000 description 14
- 230000001070 adhesive effect Effects 0.000 description 14
- 238000005259 measurement Methods 0.000 description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- 229910052799 carbon Inorganic materials 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 238000012544 monitoring process Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- 101100079986 Caenorhabditis elegans nrfl-1 gene Proteins 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000008676 import Effects 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000012805 post-processing Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012806 monitoring device Methods 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 239000012925 reference material Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- ZYDGCYWJDWIJCS-UHFFFAOYSA-N 1-methoxyphenazine Chemical compound C1=CC=C2N=C3C(OC)=CC=CC3=NC2=C1 ZYDGCYWJDWIJCS-UHFFFAOYSA-N 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- 208000010415 Low Vision Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 208000028389 Nerve injury Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000008764 nerve damage Effects 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical class OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- LNXVNZRYYHFMEY-UHFFFAOYSA-N 2,5-dichlorocyclohexa-2,5-diene-1,4-dione Chemical compound ClC1=CC(=O)C(Cl)=CC1=O LNXVNZRYYHFMEY-UHFFFAOYSA-N 0.000 description 1
- SENUUPBBLQWHMF-UHFFFAOYSA-N 2,6-dimethylcyclohexa-2,5-diene-1,4-dione Chemical compound CC1=CC(=O)C=C(C)C1=O SENUUPBBLQWHMF-UHFFFAOYSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 238000008458 Glucose Oxidase Reagent Methods 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- FBWADIKARMIWNM-UHFFFAOYSA-N N-3,5-dichloro-4-hydroxyphenyl-1,4-benzoquinone imine Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1N=C1C=CC(=O)C=C1 FBWADIKARMIWNM-UHFFFAOYSA-N 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Chemical class C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 239000012327 Ruthenium complex Substances 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- DSVGQVZAZSZEEX-UHFFFAOYSA-N [C].[Pt] Chemical compound [C].[Pt] DSVGQVZAZSZEEX-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000013142 basic testing Methods 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- IXZISFNWUWKBOM-ARQDHWQXSA-N fructosamine Chemical compound NC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O IXZISFNWUWKBOM-ARQDHWQXSA-N 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000013035 low temperature curing Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- 150000002908 osmium compounds Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000002572 performance enhancing substance Substances 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 150000002988 phenazines Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000002824 redox indicator Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150053—Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
- A61B5/150061—Means for enhancing collection
- A61B5/150068—Means for enhancing collection by tissue compression, e.g. with specially designed surface of device contacting the skin area to be pierced
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150053—Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
- A61B5/150061—Means for enhancing collection
- A61B5/150083—Means for enhancing collection by vibration, e.g. ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150503—Single-ended needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150526—Curved or bent needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150763—Details with identification means
- A61B5/150793—Electrical or magnetic identification means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150847—Communication to or from blood sampling device
- A61B5/15087—Communication to or from blood sampling device short range, e.g. between console and disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/155—Devices specially adapted for continuous or multiple sampling, e.g. at predetermined intervals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6957—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/08—Sensors provided with means for identification, e.g. barcodes or memory chips
- A61B2562/085—Sensors provided with means for identification, e.g. barcodes or memory chips combined with means for recording calibration data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150175—Adjustment of penetration depth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15186—Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Optics & Photonics (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Computer Networks & Wireless Communication (AREA)
- Primary Health Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
【選択図】図1
Description
Claims (52)
- センサが流体に露出した場合に、測定可能な特性である、前記流体の中の分析物の濃度、および前記センサの較正量の関数を作成し、前記較正量を表す情報を受信、保存および伝達するように構成された無線装置を組み込むセンサを較正する方法であって、
前記較正量を表す前記情報を前記センサに組み込まれた前記無線装置に無線で送信するステップを有する、ことを特徴とする方法。 - センサが流体に露出した場合に、測定可能な特性である、前記流体の中の分析物の濃度、および前記センサの較正量の関数を作成し、前記較正量を表す情報を受信、保存および伝達するように構成された無線装置を有し、センサを製造する方法であって、
前記較正量を保有するとともに前記無線装置を含むように少なくとも部分的に前記センサを製造するステップと、
前記較正量を表す情報を前記無線装置に無線で送信するステップと、
選択的に前記センサの前記製造を終了するステップとを有する、ことを特徴とする方法。 - 前記センサは、測光センサもしくは比色センサであり、
測定可能な特性は、不透明性、透明性、蛍光強度、透過率、反射率、吸収性もしくは放射率、透過率、反射、吸収、放射もしくは励起スペクトル、ピーク、傾斜もしくは比率、そのようなスペクトルの任意の部品の一つ、色度、放射偏光、励起状態寿命、蛍光発光の消光、前記のいずれかにおける経時的な変化、前記の任意の組合せ、もしくはその他の、前記露出されているセンサにおいて前記流体がその光学上の特徴に影響する範囲の指標を含む、ことを特徴とする請求項1または請求項2に記載の方法。 - 前記測光センサもしくは比色センサは、基板および少なくとも第1試薬を有する、ことを特徴とする請求項3記載の方法。
- 前記試薬は、触媒および染料、もしくは染料前駆体および触媒反応を含み、前記分析物が存在する場合には、前期染料を変性させる、もしくは前記染料前駆体を染料に変換する、ことを特徴とする請求項4に記載の方法。
- 前記分析物は、ブドウ糖、ヘモグロビンエーワンシー、乳酸塩、コレステロール、アルコール、ケトン、乳酸塩、治療薬剤、休養娯楽薬、性能強化薬、病気条件を示すビオマーカ、ホルモン、抗体、前記すべての物質の代謝物、前記すべての物質の組合せ、他の類似のインジケータである、ことを特徴とする請求項3乃至5のいずれか1つに記載の方法。
- 前記分析物はブドウ糖で、前期触媒はグルコースオキシターゼとホースラディッシュペルオキシダーゼの組合せであり、前記試薬はロイコーダイを含む、ことを特徴とする請求項5に記載の方法。
- 前記ロイコーダイは、3−ジメチルアミノ−ベンゾイカシッドと共に、2,2アジノ−ジ−[3−エチルベンジアゾリン−サルフォネート]、テタメチルベリジディン−ヒドロクロリッドおよび3−メチル−2−ベンゾチアゾリン−ヒドラゾンである、請求項7に記載の方法。
- 少なくとも部分的にセンサを製造することは、試薬フィルムの位置合わせ、もしくは基板中の開口部を覆う膜を有する、ことを特徴とする請求項3乃至8のいずれか1つに記載の方法。
- 少なくとも部分的にセンサを製造することは、試薬フィルムの位置合わせ、もしくは基板の一部を覆う膜を有する、ことを特徴とする請求項3乃至8のいずれか1つに記載の方法。
- 少なくとも部分的にセンサを製造することは、基板中の室の中に試薬を設置することを含む、ことを特徴とする請求項3乃至8のいずれか1つに記載の方法。
- 前記センサは、電極を備えた電気化学センサであって、測定可能な特性は、電極間のインピーダンス、電極間の電流、電位差、電荷の量、前記の任意の経時的な変化、前記の任意の組み合わせ、もしくは1つの電極から他の電極へ移動する電気の量のその他のインジケータ、もしくはセンサの流体への露出が電気エネルギまたは電荷を生成する程度かまたはセンサの電気特性に影響を与える程度が測定できる特性である、ことを特徴とする請求項1または請求項2に記載の方法。
- 前記電気化学センサは、基板、電極を含む電極層、および少なくとも第1の試薬層を有する、ことを特徴とする請求項12に記載の方法。
- 前記センサは、電極を備えた電気化学センサであって、少なくとも部分的に前記センサを製造することは、基板上に電極を含む電極層を堆積し、基板上の試薬層を堆積することを含む、ことを特徴とする請求項2に記載の方法。
- 前記試薬層は、前記電極層を覆って堆積している、ことを特徴とする請求項14に記載の方法。
- 前記較正量を表す情報を前記センサに送信する前に、前記センサに無線装置を取り付けることをさらに含む、ことを特徴とする請求項2乃至15のいずれか1つに記載の方法。
- 少なくとも部分的に前記センサを製造することは、前記無線装置の部品を堆積することを含む、ことを特徴とする請求項14または請求項15に記載の方法。
- 前記無線装置の部品は、前記電極層の中に堆積される、ことを特徴とする請求項17に記載の方法。
- 前記部品は、アンテナである、ことを特徴とする請求項17または請求項18に記載の方法。
- 前記アンテナは、コイルである、ことを特徴とする請求項19に記載の方法。
- 前記アンテナは、マイクロストリップアンテナである、ことを特徴とする請求項19に記載の方法。
- 前記電極層の中の前記電極は、マイクロストリップアンテナを形成する、ことを特徴とする請求項21に記載の方法。
- 少なくとも部分的に前記センサを製造することは、前記無線装置の残存部品を前記センサに取り付け、前記較正量を表す情報が前記センサに送信される前に、前記センサと電気接触することをさらに含む、ことを特徴とする請求項17乃至22のいずれか1つに記載の方法。
- 少なくとも部分的に前記センサを製造することは、絶縁層を前記電極層の上に堆積し、前記試薬層を前記絶縁層の上に堆積し、前記絶縁層は選択された1またはそれ以上の接触領域以外での前記電極と前期試薬層との間での接触を防止する、ことを特徴とする請求項14、請求項15、請求項17乃至23のいずれか1つに記載の方法。
- 少なくとも部分的に前記センサを製造することは、第2試薬層を第1試薬層の上に堆積することをさらに含む、ことを特徴とする請求項14乃至24のいずれか1つに記載の方法。
- 前記第2試薬層は、電子輸送媒介物質を有する、ことを特徴とする請求項25に記載の方法。
- 前記電子輸送媒介物質は、フェシリアン化物である、ことを特徴とする請求項26に記載の方法。
- 前記少なくとも一つの層の堆積は印刷プロセスによる、ことを特徴とする請求項14乃至27のいずれか1つに記載の方法。
- 前記印刷プロセスは、スクリーン印刷、インクジェット印刷、リソグラフィ、フレキソグラフィ、グラビア印刷、輪転グラビア印刷、レーザマーキング、ストッロ/ダイコーティングまたはスプレーコーティングである、ことを特徴とする請求項28に記載の方法。
- 前記印刷プロセスは、シリンダスクリーン印刷である、ことを特徴とする請求項29に記載の方法。
- 複数のセンサは、バッチ中で製造される、ことを特徴とする請求項2乃至30のいずれか1つに記載の方法。
- 複数のセンサは、単一の基板上のバッチ中で製造される、請求項4、請求項5、請求項9乃至11、請求項13乃至30のいずれか1つに記載の方法。
- 複数のセンサは、連続プロセスで製造される、ことを特徴とする請求項2乃至30のいずれか1つに記載の方法。
- 複数のセンサは、連続プロセスにおける基板の連続ウエブの上で製造される、ことを特徴とする請求項4、請求項5、請求項9乃至11、請求項13乃至30のいずれか1つに記載の方法。
- 前記複数のセンサは、電極を備えた電気化学センサであって、測定可能な特性は、露出されている前記センサにおいて前記流体が前記センサの前記電気的特長に影響する範囲の指標であって、
電極堆積装置および試薬堆積装置を介して、連続ウエブを連続的に通過し、
前記電極堆積装置において、各センサの電極を含む電極層を堆積し、
前記試薬堆積装置において、各センサの試薬層を前記電極層の上に堆積する、ことを特徴とする請求項34に記載の方法。 - 絶縁層堆積装置を介して連続ウエブを連続的に通過し、
前記絶縁層堆積装置において、各センサの絶縁層を前記電極の上に堆積し、
前記試薬堆積装置において、各センサの試薬層を前記絶縁層の上に堆積し、
前記絶縁層が電極と試薬との間でのコンタクトを選択されたゾーン以外で防止することをさらに含む、ことを特徴とする請求項35記載の方法。 - 第2試薬堆積装置を介して連続ウエブを連続的に通過し、
第2試薬堆積装置において、各センサの第2試薬層を前記第1試薬層の上に堆積することをさらに含む、ことを特徴とする請求項33または請求項34に記載の方法。 - 無線装置固定装置を介して連続ウエブを連続的に通過し、
無線装置固定装置において、無線装置を各センサに固定することをさらに含む、ことを特徴とする請求項35乃至37のいずれか1つに記載の方法。 - 前記ウエブに電気化学センサを堆積後、前記ウエブをリボン状に切断し、各リボンは複数のセンサを収容することをさらに含む、ことを特徴とする請求項35乃至38のいずれか1つに記載の方法。
- センサを保護容器の中に設置し、
その後、前記センサの前記較正量を表す情報を前記無線装置のセンサに無線で送信することを含む、ことを特徴とする請求項2乃至39のいずれか1つに記載の方法。 - 同一の較正量を表す情報は、前記無線装置の複数のセンサに同時に、またはほぼ同時に送信される、ことを特徴とする請求項31乃至39のいずれか1つに記載の方法。
- 複数のセンサを保護容器の中に設置し、
前記同一の較正量を表す情報を前記無線装置の複数のセンサに同時に、またはほぼ同時に無線で送信する、ことを特徴とする請求項41に記載の方法。 - 前記分析物は、ブドウ糖、乳酸塩、尿酸塩、アルコール、治療薬剤、休養娯楽薬、性能強化薬、病気条件を示すビオマーカ、ホルモン、抗体、前記すべての物質の代謝物、前記すべての物質の組合せ、他の類似のインジケータである、ことを特徴とする請求項1乃至42のいずれか1つに記載の方法。
- 前記分析物は、ブドウ糖である、ことを特徴とする請求項43に記載の方法。
- 前記試薬層は、グルコース酸化物を含む、ことを特徴とする請求項13乃至32、請求項34乃至44のいずれか1つに記載の方法。
- 基板と、電極を含む電極層と、少なくとも第1試薬層とを有する電気化学センサであって、
センサが流体に露出した場合に、流体の中の分析物の濃度関数である測定可能な電気的特性を作成し、
前記電極層の中の電極によって形成されたマイクロストリップアンテナを含み、情報を受信、保存および伝達するよう構成された無線装置をさらに含む、ことを特徴とする電気化学センサ。 - センサが流体に露出した場合に、測定可能な特性である、前記流体の中の分析物の濃度、および前記センサの較正量の関数を作成し、前記較正量を表す情報を受信、保存および伝達するように構成された無線装置を有し、センサを製造する方法であって、
前記較正量を保有するとともに前記無線装置を含むように前記センサの製造を終了するステップと、
前記較正量を表す情報を前記無線装置に無線で送信するステップとを有する、ことを特徴とするセンサを製造する方法。 - センサが流体に露出した場合に、測定可能な特性である、前記流体の中の分析物の濃度、および前記センサの較正量の関数を作成し、
前記較正量を表す情報を受信、保存および伝達するように構成された無線装置を有し、
前記無線装置は、前記センサの前記較正量を表す情報を含む、ことを特徴とするセンサ。 - 前記無線装置は、無線通信によって情報を受信および伝達する、ことを特徴とする請求項1乃至45のいずれか1つ、請求項47、請求項46または請求項48に記載の方法。
- 前記無線装置は、RFIDタグである、ことを特徴とする請求項1乃至45のいずれか1つ、請求項47、請求項46または請求項48に記載の方法。
- 請求項2乃至45のいずれか1つ、または請求項47に記載の方法に従って製造した、ことを特徴とするセンサ。
- 請求項1に記載の方法に従って較正した、ことを特徴とするセンサ。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60633404P | 2004-08-31 | 2004-08-31 | |
US60/606,334 | 2004-08-31 | ||
PCT/US2005/031286 WO2006026748A1 (en) | 2004-08-31 | 2005-08-31 | Method of manufacturing an auto-calibrating sensor |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008511841A true JP2008511841A (ja) | 2008-04-17 |
JP5032321B2 JP5032321B2 (ja) | 2012-09-26 |
Family
ID=35482826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007530391A Expired - Fee Related JP5032321B2 (ja) | 2004-08-31 | 2005-08-31 | 自動較正センサの製造方法 |
Country Status (5)
Country | Link |
---|---|
US (2) | US20070270672A1 (ja) |
EP (1) | EP1794585A1 (ja) |
JP (1) | JP5032321B2 (ja) |
CN (1) | CN101091114A (ja) |
WO (2) | WO2006026748A1 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010107512A (ja) * | 2008-10-30 | 2010-05-13 | Lifescan Scotland Ltd | 最小充填ミス試料観察窓を有する分析テストストリップ |
JP2010525371A (ja) * | 2007-04-27 | 2010-07-22 | アボット ダイアベティス ケア インコーポレイテッド | 較正のないアナライトセンサおよび方法 |
JP2011528460A (ja) * | 2008-07-17 | 2011-11-17 | ユニバーサル バイオセンサーズ ピーティーワイ リミテッド | 色コード化領域による自動情報転送 |
JP2012504233A (ja) * | 2008-09-30 | 2012-02-16 | メナイ メディカル テクノロジーズ リミテッド | サンプル測定システム |
JP2012509482A (ja) * | 2008-11-20 | 2012-04-19 | アボット・ラボラトリーズ | 自動検査室用分析器において無線識別によってベッセルを追跡するためのシステム |
JP2012529045A (ja) * | 2009-06-04 | 2012-11-15 | イントレスコ・ベスローテン・フェンノートシャップ | Rfidチップでタグ付与されたインレーを備えたシステムを用いて、生物組織サンプルカセットを追跡可能なデバイスに転換する方法 |
JP2014500953A (ja) * | 2010-11-15 | 2014-01-16 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | ガイド付きの体系的な検査キット |
JP2016502088A (ja) * | 2012-12-04 | 2016-01-21 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | ヘマトクリットを補正する方法およびそのために適合させた血糖測定器 |
Families Citing this family (385)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
EP1404235A4 (en) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | METHOD AND DEVICE FOR A LANZETTING DEVICE INTEGRATED ON A BLOOD CARTRIDGE CARTRIDGE |
ES2352998T3 (es) | 2001-06-12 | 2011-02-24 | Pelikan Technologies Inc. | Accionador eléctrico de lanceta. |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
ATE450210T1 (de) | 2001-06-12 | 2009-12-15 | Pelikan Technologies Inc | Selbstoptimierende lanzettenvorrichtung mit adaptationsmittel für zeitliche schwankungen von hauteigenschaften |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US20070227907A1 (en) | 2006-04-04 | 2007-10-04 | Rajiv Shah | Methods and materials for controlling the electrochemistry of analyte sensors |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US8771183B2 (en) | 2004-02-17 | 2014-07-08 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US7587287B2 (en) | 2003-04-04 | 2009-09-08 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US7679407B2 (en) | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
EP1628567B1 (en) | 2003-05-30 | 2010-08-04 | Pelikan Technologies Inc. | Method and apparatus for fluid injection |
WO2004107964A2 (en) | 2003-06-06 | 2004-12-16 | Pelikan Technologies, Inc. | Blood harvesting device with electronic control |
US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US7722536B2 (en) | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
WO2005033659A2 (en) | 2003-09-29 | 2005-04-14 | Pelikan Technologies, Inc. | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | METHOD AND APPARATUS PROVIDING A VARIABLE USER INTERFACE |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US7679563B2 (en) | 2004-01-14 | 2010-03-16 | The Penn State Research Foundation | Reconfigurable frequency selective surfaces for remote sensing of chemical and biological agents |
WO2006011062A2 (en) | 2004-05-20 | 2006-02-02 | Albatros Technologies Gmbh & Co. Kg | Printable hydrogel for biosensors |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | METHOD AND APPARATUS FOR MANUFACTURING A DEVICE FOR SAMPLING LIQUIDS |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
CA3110101A1 (en) | 2004-06-04 | 2005-12-15 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US9044199B2 (en) | 2004-07-13 | 2015-06-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9351669B2 (en) | 2009-09-30 | 2016-05-31 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
WO2006094513A2 (en) * | 2005-03-09 | 2006-09-14 | Coloplast A/S | A three-dimensional adhesive device having a microelectronic system embedded therein |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
US8730031B2 (en) | 2005-04-28 | 2014-05-20 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
EP1889198B1 (en) | 2005-04-28 | 2014-11-26 | Proteus Digital Health, Inc. | Pharma-informatics system |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US8016154B2 (en) * | 2005-05-25 | 2011-09-13 | Lifescan, Inc. | Sensor dispenser device and method of use |
WO2006131697A2 (en) * | 2005-06-10 | 2006-12-14 | Hypoguard Limited | Test system |
EP1921980A4 (en) | 2005-08-31 | 2010-03-10 | Univ Virginia | IMPROVING THE PRECISION OF CONTINUOUS GLUCOSE SENSORS |
EP1920418A4 (en) | 2005-09-01 | 2010-12-29 | Proteus Biomedical Inc | IMPLANTABLE WIRELESS COMMUNICATION SYSTEMS |
JP4921757B2 (ja) * | 2005-09-27 | 2012-04-25 | ルネサスエレクトロニクス株式会社 | Icタグ、icタグシステム及びそのコマンドの実行方法 |
US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
DK1957973T3 (en) * | 2005-11-29 | 2016-07-04 | Alco Systems Sweden Ab | System and method for establishing a time when bac crossing the threshold level |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
WO2007101141A2 (en) * | 2006-02-24 | 2007-09-07 | Hmicro, Inc. | A medical signal processing system with distributed wireless sensors |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
CA2883977A1 (en) * | 2006-03-23 | 2007-10-04 | Becton, Dickinson And Company | System and methods for improved diabetes data management and use employing wireless connectivity between patients and healthcare providers and repository of diabetes management information |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
US7801582B2 (en) | 2006-03-31 | 2010-09-21 | Abbott Diabetes Care Inc. | Analyte monitoring and management system and methods therefor |
US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
US9326709B2 (en) | 2010-03-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US8478557B2 (en) | 2009-07-31 | 2013-07-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
WO2007121763A1 (en) | 2006-04-20 | 2007-11-01 | Lifescan Scotland Limited | Method for transmitting data in a blood glucose system and corresponding blood glucose system |
US8956287B2 (en) | 2006-05-02 | 2015-02-17 | Proteus Digital Health, Inc. | Patient customized therapeutic regimens |
WO2007134622A1 (en) * | 2006-05-22 | 2007-11-29 | Lifescan Scotland Limited | Blood glucose level measurement and wireless transmission unit |
WO2007140511A1 (en) * | 2006-06-02 | 2007-12-13 | Cbb International Pty Ltd | A monitoring system |
US20070287991A1 (en) * | 2006-06-08 | 2007-12-13 | Mckay William F | Devices and methods for detection of markers of axial pain with or without radiculopathy |
US20070298487A1 (en) * | 2006-06-23 | 2007-12-27 | Becton, Dickinson And Company | Radio Frequency Transponder Assay |
US7880590B2 (en) | 2006-07-18 | 2011-02-01 | Hewlett-Packard Development Company, L.P. | Method and apparatus for localization of configurable devices |
US7852198B2 (en) * | 2006-07-18 | 2010-12-14 | Hewlett-Packard Development Company, L.P. | RF tag |
US8932216B2 (en) | 2006-08-07 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US8206296B2 (en) | 2006-08-07 | 2012-06-26 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
JP4974816B2 (ja) * | 2006-09-13 | 2012-07-11 | 株式会社半導体エネルギー研究所 | 検査素子及び検査容器 |
EP1901058A3 (en) | 2006-09-13 | 2010-02-17 | Semiconductor Energy Laboratory Co., Ltd. | Examination element and examination container for testing liquid samples |
EP2050039A2 (en) | 2006-10-13 | 2009-04-22 | Aspect Medical System, Inc. | A system for detecting and communicating with rfid memory devices |
WO2008066617A2 (en) | 2006-10-17 | 2008-06-05 | Proteus Biomedical, Inc. | Low voltage oscillator for medical devices |
KR101611240B1 (ko) | 2006-10-25 | 2016-04-11 | 프로테우스 디지털 헬스, 인코포레이티드 | 복용 가능한 제어된 활성화 식별자 |
US20080164142A1 (en) * | 2006-10-27 | 2008-07-10 | Manuel Alvarez-Icaza | Surface treatment of carbon composite material to improve electrochemical properties |
US8718193B2 (en) | 2006-11-20 | 2014-05-06 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
WO2008068078A1 (en) * | 2006-12-07 | 2008-06-12 | International Business Machines Corporation | Remote controller having an rfid tag |
MY165532A (en) | 2007-02-01 | 2018-04-02 | Proteus Digital Health Inc | Ingestible event marker systems |
CN101636865B (zh) | 2007-02-14 | 2012-09-05 | 普罗秋斯生物医学公司 | 具有高表面积电极的体内电源 |
US8121857B2 (en) | 2007-02-15 | 2012-02-21 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US20080199894A1 (en) | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
WO2008112577A1 (en) | 2007-03-09 | 2008-09-18 | Proteus Biomedical, Inc. | In-body device having a multi-directional transmitter |
EP2063771A1 (en) | 2007-03-09 | 2009-06-03 | Proteus Biomedical, Inc. | In-body device having a deployable antenna |
US7713196B2 (en) * | 2007-03-09 | 2010-05-11 | Nellcor Puritan Bennett Llc | Method for evaluating skin hydration and fluid compartmentalization |
EP2146624B1 (en) | 2007-04-14 | 2020-03-25 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2009096992A1 (en) | 2007-04-14 | 2009-08-06 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
US8140142B2 (en) | 2007-04-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2008130898A1 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2008130896A1 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
US9693708B2 (en) * | 2007-05-04 | 2017-07-04 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Systems and methods for wireless transmission of biopotentials |
EP1988394A1 (de) | 2007-05-04 | 2008-11-05 | F. Hoffmann-La Roche AG | Messsystem mit verteilten Funktionen |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9050379B2 (en) * | 2007-05-08 | 2015-06-09 | Finesse Solutions, Inc. | Bioprocess data management |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
US20080304721A1 (en) * | 2007-06-11 | 2008-12-11 | Tzu-Chiang Wu | Image detection method for diagnostic plates |
WO2008157821A1 (en) * | 2007-06-21 | 2008-12-24 | Abbott Diabetes Care, Inc. | Health monitor |
AU2015275271B2 (en) * | 2007-06-21 | 2017-11-09 | Abbott Diabetes Care Inc. | Health monitor |
WO2008157820A1 (en) | 2007-06-21 | 2008-12-24 | Abbott Diabetes Care, Inc. | Health management devices and methods |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
CA2693498A1 (en) | 2007-08-06 | 2009-02-12 | Bayer Healthcare Llc | System and method for automatic calibration |
TW200912309A (en) * | 2007-09-04 | 2009-03-16 | Kaiwood Technology Co Ltd | System configuration method of color indicating chip analyzer |
US8164453B2 (en) * | 2007-09-19 | 2012-04-24 | Chung Shan Institute Of Science And Technology, Armaments Bureau, M.N.D. | Physical audit system with radio frequency identification and method thereof |
PT2192946T (pt) | 2007-09-25 | 2022-11-17 | Otsuka Pharma Co Ltd | Dispositivo no corpo com amplificação de sinal dipolo virtual |
US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
US8409093B2 (en) | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
US20110019824A1 (en) | 2007-10-24 | 2011-01-27 | Hmicro, Inc. | Low power radiofrequency (rf) communication systems for secure wireless patch initialization and methods of use |
EP3300661A1 (en) | 2007-10-24 | 2018-04-04 | Hmicro, Inc. | Method and apparatus to retrofit wired healthcare and fitness systems for wireless operation |
JP5102583B2 (ja) * | 2007-11-12 | 2012-12-19 | シスメックス株式会社 | 分析装置 |
EP2065870A1 (en) | 2007-11-21 | 2009-06-03 | Roche Diagnostics GmbH | Medical device for visually impaired users and users not visually impaired |
EP2220495A1 (en) * | 2007-11-29 | 2010-08-25 | Receptors LLC | Sensors employing combinatorial artificial receptors |
US8001825B2 (en) * | 2007-11-30 | 2011-08-23 | Lifescan, Inc. | Auto-calibrating metering system and method of use |
US7933919B2 (en) * | 2007-11-30 | 2011-04-26 | Microsoft Corporation | One-pass sampling of hierarchically organized sensors |
JP4944083B2 (ja) * | 2007-12-12 | 2012-05-30 | パナソニック株式会社 | 生体試料測定用試験片および生体試料測定装置 |
US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
USD612279S1 (en) | 2008-01-18 | 2010-03-23 | Lifescan Scotland Limited | User interface in an analyte meter |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
JP5738529B2 (ja) * | 2008-02-07 | 2015-06-24 | アークレイ株式会社 | コード読み取り装置およびこれを用いたデータ収集システム |
KR20110004845A (ko) * | 2008-02-27 | 2011-01-14 | 엠오엔4디 엘티디 | 모듈식 분석물 모니터링 장치, 시스템 및 방법 |
EP3827811A1 (en) | 2008-03-05 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Multi-mode communication ingestible event markers and systems |
US7919326B2 (en) * | 2008-03-14 | 2011-04-05 | International Business Machines Corporation | Tracking a status of a catalyst-driven process using RFIDs |
USD611853S1 (en) | 2008-03-21 | 2010-03-16 | Lifescan Scotland Limited | Analyte test meter |
USD615431S1 (en) | 2008-03-21 | 2010-05-11 | Lifescan Scotland Limited | Analyte test meter |
IL197532A0 (en) | 2008-03-21 | 2009-12-24 | Lifescan Scotland Ltd | Analyte testing method and system |
USD612275S1 (en) | 2008-03-21 | 2010-03-23 | Lifescan Scotland, Ltd. | Analyte test meter |
ES2326020B1 (es) * | 2008-03-27 | 2010-06-25 | Libelium Comunicaciones Distribuidas, S.L. | Sistema autonomo de deteccion, medida, geolocalizacion, respuesta y comunicacion. |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US7826382B2 (en) | 2008-05-30 | 2010-11-02 | Abbott Diabetes Care Inc. | Close proximity communication device and methods |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
USD611151S1 (en) | 2008-06-10 | 2010-03-02 | Lifescan Scotland, Ltd. | Test meter |
JP5654988B2 (ja) | 2008-07-08 | 2015-01-14 | プロテウス デジタル ヘルス, インコーポレイテッド | 摂取型事象マーカデータフレームワーク |
WO2010009459A1 (en) * | 2008-07-18 | 2010-01-21 | Bayer Healthcare Llc | Methods, devices, and systems for glycated hemoglobin analysis |
USD611489S1 (en) | 2008-07-25 | 2010-03-09 | Lifescan, Inc. | User interface display for a glucose meter |
JP5715564B2 (ja) | 2008-08-13 | 2015-05-07 | プロテウス デジタル ヘルス, インコーポレイテッド | 摂取可能デバイスおよびそれを生成する方法 |
US9943644B2 (en) | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US20100057040A1 (en) | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
USD611372S1 (en) | 2008-09-19 | 2010-03-09 | Lifescan Scotland Limited | Analyte test meter |
WO2010033878A2 (en) * | 2008-09-19 | 2010-03-25 | David Brown | Solute concentration measurement device and related methods |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
US8097926B2 (en) | 2008-10-07 | 2012-01-17 | Mc10, Inc. | Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy |
US9289132B2 (en) | 2008-10-07 | 2016-03-22 | Mc10, Inc. | Catheter balloon having stretchable integrated circuitry and sensor array |
US8389862B2 (en) | 2008-10-07 | 2013-03-05 | Mc10, Inc. | Extremely stretchable electronics |
US9123614B2 (en) | 2008-10-07 | 2015-09-01 | Mc10, Inc. | Methods and applications of non-planar imaging arrays |
US20100112612A1 (en) * | 2008-10-30 | 2010-05-06 | John William Dilleen | Method for determining an analyte using an analytical test strip with a minimal fill-error viewing window |
US8036748B2 (en) | 2008-11-13 | 2011-10-11 | Proteus Biomedical, Inc. | Ingestible therapy activator system and method |
US8055334B2 (en) | 2008-12-11 | 2011-11-08 | Proteus Biomedical, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
TWI503101B (zh) | 2008-12-15 | 2015-10-11 | Proteus Digital Health Inc | 與身體有關的接收器及其方法 |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
AU2010203737B2 (en) | 2009-01-06 | 2016-09-15 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical dosages delivery system |
AU2010203625A1 (en) | 2009-01-06 | 2011-07-21 | Proteus Digital Health, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US20100198034A1 (en) | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
US8394246B2 (en) * | 2009-02-23 | 2013-03-12 | Roche Diagnostics Operations, Inc. | System and method for the electrochemical measurement of an analyte employing a remote sensor |
WO2012021792A2 (en) * | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Clinical and/or consumer techniques and devices |
WO2010111403A2 (en) | 2009-03-25 | 2010-09-30 | Proteus Biomedical, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
WO2010127050A1 (en) | 2009-04-28 | 2010-11-04 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
EP3906845A1 (en) | 2009-04-28 | 2021-11-10 | Otsuka Pharmaceutical Co., Ltd. | Highly reliable ingestible event markers |
EP2424426B1 (en) | 2009-04-29 | 2020-01-08 | Abbott Diabetes Care, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
WO2010127051A1 (en) | 2009-04-29 | 2010-11-04 | Abbott Diabetes Care Inc. | Method and system for providing real time analyte sensor calibration with retrospective backfill |
WO2010132331A2 (en) | 2009-05-12 | 2010-11-18 | Proteus Biomedical, Inc. | Ingestible event markers comprising an ingestible component |
US9184490B2 (en) | 2009-05-29 | 2015-11-10 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
EP3932309A1 (en) | 2009-07-23 | 2022-01-05 | Abbott Diabetes Care, Inc. | Continuous analyte measurement system |
EP3936032B1 (en) | 2009-07-23 | 2024-05-29 | Abbott Diabetes Care, Inc. | Real time management of data relating to physiological control of glucose levels |
US8641671B2 (en) | 2009-07-30 | 2014-02-04 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
BR112012003078A2 (pt) * | 2009-08-17 | 2019-09-24 | Univ California | sistema de sensor externo interrogável para obter uma ou mais características biológicas de uma superfície ou região de tecido interno do corpo de um paciente, método para obter uma ou mais características biológicas de uma superfície ou regiaõ de tecido interno de um paciente, sistema de sensor transdérmico para obter uma ou mais características biológicas de uma regiaõ de tecido interno de paciente, método para obter uma ou mais características biológicas de uma região do tecido interno de um paciente e sistema de sensor interrogável para obter uma oumais características biológicas de uma regiaõ de tecido interno de um paciente |
US8558563B2 (en) | 2009-08-21 | 2013-10-15 | Proteus Digital Health, Inc. | Apparatus and method for measuring biochemical parameters |
WO2011026148A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
JP5795584B2 (ja) | 2009-08-31 | 2015-10-14 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | 医療用装置 |
ES2952361T3 (es) | 2009-08-31 | 2023-10-31 | Abbott Diabetes Care Inc | Visualizadores para un dispositivo médico |
WO2011041469A1 (en) | 2009-09-29 | 2011-04-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US9723122B2 (en) | 2009-10-01 | 2017-08-01 | Mc10, Inc. | Protective cases with integrated electronics |
US8690820B2 (en) * | 2009-10-06 | 2014-04-08 | Illinois Institute Of Technology | Automatic insulin pumps using recursive multivariable models and adaptive control algorithms |
TWI517050B (zh) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | 供應鏈管理之系統 |
UA109424C2 (uk) | 2009-12-02 | 2015-08-25 | Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки | |
KR101798128B1 (ko) | 2010-02-01 | 2017-11-16 | 프로테우스 디지털 헬스, 인코포레이티드 | 데이터 수집 시스템 |
DK3622883T3 (da) | 2010-03-24 | 2021-07-19 | Abbott Diabetes Care Inc | Indførerer til medicinsk indretning og fremgangsmåder til at indføre og anvende medicinske indretninger |
JP6463599B2 (ja) | 2010-04-07 | 2019-02-06 | プロテウス デジタル ヘルス, インコーポレイテッド | 小型の摂取可能なデバイス |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
TWI557672B (zh) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置 |
US8635046B2 (en) | 2010-06-23 | 2014-01-21 | Abbott Diabetes Care Inc. | Method and system for evaluating analyte sensor response characteristics |
EP2400411A1 (de) | 2010-06-24 | 2011-12-28 | Roche Diagnostics GmbH | Analysesystem mit erweiterter Benutzerinformation |
US20130158482A1 (en) | 2010-07-26 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
WO2012048168A2 (en) | 2010-10-07 | 2012-04-12 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods |
DK2629892T3 (da) * | 2010-10-20 | 2022-07-04 | Siemens Healthineers Nederland B V | Indretning med rfid-mærke og strømningsteknisk element |
JP6055773B2 (ja) | 2010-11-09 | 2016-12-27 | セブンス センス バイオシステムズ,インコーポレーテッド | 血液サンプリングのためのシステムおよびインターフェース |
EP2642983A4 (en) | 2010-11-22 | 2014-03-12 | Proteus Digital Health Inc | DEVICE INGREABLE WITH PHARMACEUTICAL PRODUCT |
US9946836B2 (en) | 2011-01-31 | 2018-04-17 | Robert Bosch Gmbh | Biomarker monitoring device and method |
WO2012154286A1 (en) | 2011-02-28 | 2012-11-15 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
WO2012125425A2 (en) | 2011-03-11 | 2012-09-20 | Proteus Biomedical, Inc. | Wearable personal body associated device with various physical configurations |
WO2012129796A1 (en) * | 2011-03-30 | 2012-10-04 | Siemens Aktiengesellschaft | A method for configuring a wireless device and a wireless device and system |
KR20140034200A (ko) | 2011-04-29 | 2014-03-19 | 세븐쓰 센스 바이오시스템즈, 인크. | 혈액 스폿들 또는 다른 신체 유체들을 수집 및/또는 조작하기 위한 시스템들 및 방법들 |
EP2712491B1 (en) | 2011-05-27 | 2019-12-04 | Mc10, Inc. | Flexible electronic structure |
US20120306628A1 (en) * | 2011-05-31 | 2012-12-06 | Tara Chand Singhal | Integrated blood glucose measurement device with a test strip count system |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
RU2014106126A (ru) | 2011-07-21 | 2015-08-27 | Протеус Диджитал Хелс, Инк. | Устройство, система и способ мобильной связи |
DE112012003250T5 (de) | 2011-08-05 | 2014-04-30 | Mc10, Inc. | Katheder Ballon-Verfahren und Vorrichtung unter Einsatz von Abtastelementen |
WO2013066873A1 (en) | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
WO2013066849A1 (en) | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US9235683B2 (en) * | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
WO2013078426A2 (en) | 2011-11-25 | 2013-05-30 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
CN103175872A (zh) * | 2011-12-23 | 2013-06-26 | 长沙中生众捷生物技术有限公司 | 便携式电化学检测试纸条及其制备方法 |
US20150238131A1 (en) * | 2012-01-10 | 2015-08-27 | Sanofi-Aventis Deutschland Gmbh | Apparatus having a light emitting part |
EP2802263B1 (en) | 2012-01-10 | 2016-07-20 | Sanofi-Aventis Deutschland GmbH | A blood analysis meter |
EP2626755B1 (en) * | 2012-02-10 | 2019-04-10 | Nxp B.V. | Calibration method, calibration device and measurement device |
US10265514B2 (en) | 2014-02-14 | 2019-04-23 | Medtronic, Inc. | Sensing and stimulation system |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9555186B2 (en) | 2012-06-05 | 2017-01-31 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US9226402B2 (en) | 2012-06-11 | 2015-12-29 | Mc10, Inc. | Strain isolation structures for stretchable electronics |
US9295842B2 (en) | 2012-07-05 | 2016-03-29 | Mc10, Inc. | Catheter or guidewire device including flow sensing and use thereof |
US9168094B2 (en) | 2012-07-05 | 2015-10-27 | Mc10, Inc. | Catheter device including flow sensing |
CA2897198A1 (en) | 2012-07-23 | 2014-01-30 | Proteus Digital Health, Inc. | Techniques for manufacturing ingestible event markers comprising an ingestible component |
KR20150037886A (ko) | 2012-07-26 | 2015-04-08 | 바이엘 헬쓰케어, 엘엘씨 | 바이오센서 측정기로부터의 감전 사고 위험을 감소시키는 장치 및 방법 |
EP2890297B1 (en) | 2012-08-30 | 2018-04-11 | Abbott Diabetes Care, Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
EP2901153A4 (en) | 2012-09-26 | 2016-04-27 | Abbott Diabetes Care Inc | METHOD AND DEVICE FOR IMPROVING DELAY CORRECTION FUNCTION DURING IN VIVO MEASUREMENT OF ANALYZ CONCENTRATION WITH ANALYZ CONCENTRATION VARIABILITY AND RANGE DATA |
KR20150072415A (ko) | 2012-10-09 | 2015-06-29 | 엠씨10, 인크 | 의류에 집적되는 컨포멀 전자기기 |
GB2506858A (en) * | 2012-10-09 | 2014-04-16 | Elcometer Ltd | Measuring instrument that reads data provided on another article |
US9171794B2 (en) | 2012-10-09 | 2015-10-27 | Mc10, Inc. | Embedding thin chips in polymer |
JP5869736B2 (ja) | 2012-10-18 | 2016-02-24 | プロテウス デジタル ヘルス, インコーポレイテッド | 通信デバイス用の電源において電力消失およびブロードキャスト電力を適応的に最適化するための装置、システム、および方法 |
TWI659994B (zh) | 2013-01-29 | 2019-05-21 | 美商普羅托斯數位健康公司 | 高度可膨脹之聚合型薄膜及包含彼之組成物 |
CN104968268A (zh) | 2013-02-06 | 2015-10-07 | 加州理工学院 | 小型可植入电化学传感器设备 |
ITRM20130125A1 (it) * | 2013-03-01 | 2014-09-02 | Biochemical Systems Internat S Rl | Sistema diagnostico per la misura della glicemia utilizzabile con dispositivi elettronici portatili |
US10132745B2 (en) * | 2013-03-14 | 2018-11-20 | Mark A. Samuels | Encoded calibration device and systems and methods thereof |
WO2014159620A1 (en) | 2013-03-14 | 2014-10-02 | Samuels Mark A | Encoded calibration device and systems and methods thereof |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
WO2014144738A1 (en) | 2013-03-15 | 2014-09-18 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
WO2014151929A1 (en) | 2013-03-15 | 2014-09-25 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US10076285B2 (en) | 2013-03-15 | 2018-09-18 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
CN107831324B (zh) | 2013-03-15 | 2021-11-19 | 雅培制药有限公司 | 具有后面可进入轨道系统的自动化诊断分析仪及相关方法 |
US9706647B2 (en) | 2013-05-14 | 2017-07-11 | Mc10, Inc. | Conformal electronics including nested serpentine interconnects |
DE102013011141A1 (de) * | 2013-07-03 | 2015-01-08 | Dräger Medical GmbH | Messvorrichtung zur Messung einer Körperfunktion und Verfahren zum Betrieb einer solchen Messvorrichtung |
CN104330444A (zh) * | 2013-07-22 | 2015-02-04 | 财团法人多次元智能It融合系统研究团 | 具有近距离无线通信基础的电气化学性生物传感器及利用其测定成分的方法 |
JP2016527649A (ja) | 2013-08-05 | 2016-09-08 | エムシー10 インコーポレイテッドMc10,Inc. | 適合する電子機器を含む可撓性温度センサ |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
WO2015035304A1 (en) | 2013-09-06 | 2015-03-12 | Tandem Diabetes Care, Inc. | System and method for mitigating risk in automated medicament dosing |
MX356850B (es) | 2013-09-20 | 2018-06-15 | Proteus Digital Health Inc | Métodos, dispositivos y sistemas para recibir y decodificar una señal en presencia de ruido usando segmentos y deformaciones. |
US9577864B2 (en) | 2013-09-24 | 2017-02-21 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US10467926B2 (en) | 2013-10-07 | 2019-11-05 | Mc10, Inc. | Conformal sensor systems for sensing and analysis |
US10542918B2 (en) | 2013-10-23 | 2020-01-28 | Verily Life Sciences Llc | Modulation of a response signal to distinguish between analyte and background signals |
US9504405B2 (en) | 2013-10-23 | 2016-11-29 | Verily Life Sciences Llc | Spatial modulation of magnetic particles in vasculature by external magnetic field |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
JP6711750B2 (ja) | 2013-11-22 | 2020-06-17 | エムシー10 インコーポレイテッドMc10,Inc. | 心臓活動の検知および分析のためのコンフォーマルセンサシステム |
US9275322B2 (en) | 2013-11-25 | 2016-03-01 | VivaLnk Limited (Cayman Islands) | Stretchable multi-layer wearable tag capable of wireless communications |
DE102013113367A1 (de) * | 2013-12-03 | 2015-06-03 | Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co.KG | Verfahren zur Wartung eines Sensors sowie Kalibrierdatenübertragungseinheit |
WO2015103580A2 (en) | 2014-01-06 | 2015-07-09 | Mc10, Inc. | Encapsulated conformal electronic systems and devices, and methods of making and using the same |
US10357180B2 (en) | 2014-01-16 | 2019-07-23 | D.T.R. Dermal Therapy Research Inc. | Health monitoring system |
US10485118B2 (en) | 2014-03-04 | 2019-11-19 | Mc10, Inc. | Multi-part flexible encapsulation housing for electronic devices and methods of making the same |
EP3117206A4 (en) * | 2014-03-12 | 2017-11-15 | Mc10, Inc. | Quantification of a change in assay |
EP4151150A1 (en) | 2014-03-30 | 2023-03-22 | Abbott Diabetes Care, Inc. | Method and apparatus for determining meal start and peak events in analyte monitoring systems |
TWI559897B (en) * | 2014-03-31 | 2016-12-01 | Bionime Corp | System and method for measuring physiological parameters |
US9820690B1 (en) | 2014-07-16 | 2017-11-21 | Verily Life Sciences Llc | Analyte detection system |
US9874554B1 (en) | 2014-07-16 | 2018-01-23 | Verily Life Sciences Llc | Aptamer-based in vivo diagnostic system |
US9910035B1 (en) | 2014-07-16 | 2018-03-06 | Verily Life Sciences Llc | Polyvalent functionalized nanoparticle-based in vivo diagnostic system |
US9513666B2 (en) | 2014-07-25 | 2016-12-06 | VivaLnk, Inc. | Highly compliant wearable wireless patch having stress-relief capability |
CN105375106B (zh) * | 2014-08-07 | 2018-04-20 | 维瓦灵克有限公司(开曼群岛) | 可拉伸多层无线通信的可穿戴贴片 |
US9993203B2 (en) | 2014-09-05 | 2018-06-12 | VivaLnk, Inc. | Electronic stickers with modular structures |
WO2016049019A1 (en) * | 2014-09-22 | 2016-03-31 | University Of Cincinnati | Sweat sensing with analytical assurance |
US9899330B2 (en) | 2014-10-03 | 2018-02-20 | Mc10, Inc. | Flexible electronic circuits with embedded integrated circuit die |
US10297572B2 (en) | 2014-10-06 | 2019-05-21 | Mc10, Inc. | Discrete flexible interconnects for modules of integrated circuits |
USD781270S1 (en) | 2014-10-15 | 2017-03-14 | Mc10, Inc. | Electronic device having antenna |
US9861289B2 (en) | 2014-10-22 | 2018-01-09 | VivaLnk, Inc. | Compliant wearable patch capable of measuring electrical signals |
US9380698B1 (en) | 2014-12-05 | 2016-06-28 | VivaLnk, Inc. | Stretchable electronic patch having a foldable circuit layer |
US9378450B1 (en) | 2014-12-05 | 2016-06-28 | Vivalnk, Inc | Stretchable electronic patch having a circuit layer undulating in the thickness direction |
US9483726B2 (en) | 2014-12-10 | 2016-11-01 | VivaLnk Inc. | Three dimensional electronic patch |
CN107530004A (zh) | 2015-02-20 | 2018-01-02 | Mc10股份有限公司 | 基于贴身状况、位置和/或取向的可穿戴式设备的自动检测和构造 |
US10398343B2 (en) | 2015-03-02 | 2019-09-03 | Mc10, Inc. | Perspiration sensor |
US10646650B2 (en) | 2015-06-02 | 2020-05-12 | Illinois Institute Of Technology | Multivariable artificial pancreas method and system |
CN113349766A (zh) | 2015-07-10 | 2021-09-07 | 雅培糖尿病护理公司 | 对于生理参数进行动态葡萄糖曲线响应的系统、装置和方法 |
US10653332B2 (en) | 2015-07-17 | 2020-05-19 | Mc10, Inc. | Conductive stiffener, method of making a conductive stiffener, and conductive adhesive and encapsulation layers |
DE102015111712B4 (de) * | 2015-07-20 | 2017-06-01 | Infineon Technologies Ag | Teststreifen und System zum Bestimmen von Messdaten einer Testflüssigkeit |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
US10368788B2 (en) * | 2015-07-23 | 2019-08-06 | California Institute Of Technology | System and methods for wireless drug delivery on command |
CN104977343B (zh) * | 2015-07-23 | 2017-11-28 | 武汉大学 | 一种基于石墨烯/介孔碳纳米复合材料的高效生物传感器及其制备方法 |
US10709384B2 (en) | 2015-08-19 | 2020-07-14 | Mc10, Inc. | Wearable heat flux devices and methods of use |
CN108290070A (zh) | 2015-10-01 | 2018-07-17 | Mc10股份有限公司 | 用于与虚拟环境相互作用的方法和系统 |
US10532211B2 (en) | 2015-10-05 | 2020-01-14 | Mc10, Inc. | Method and system for neuromodulation and stimulation |
EP3420733A4 (en) | 2016-02-22 | 2019-06-26 | Mc10, Inc. | SYSTEM, DEVICE AND METHOD FOR ACQUIRING ON THE BODY OF SENSOR AND CONCENTRATOR NODE COUPLED WITH SENSOR INFORMATION |
CN108781314B (zh) | 2016-02-22 | 2022-07-08 | 美谛达解决方案公司 | 用于贴身数据和电力传输的系统、设备和方法 |
DE102016205335A1 (de) | 2016-03-31 | 2017-10-05 | Siemens Aktiengesellschaft | Testkit zur Bioanalytik und Verfahren zur Auswertung eines solchen Testkits |
WO2017184705A1 (en) | 2016-04-19 | 2017-10-26 | Mc10, Inc. | Method and system for measuring perspiration |
FI128124B (en) * | 2016-04-25 | 2019-10-15 | Teknologian Tutkimuskeskus Vtt Oy | Optical sensor, system and methods |
ES2926670T3 (es) | 2016-05-13 | 2022-10-27 | Hoffmann La Roche | Sistema de medición de analitos y procedimiento de inicialización |
EP3487393A4 (en) | 2016-07-22 | 2020-01-15 | Proteus Digital Health, Inc. | ELECTROMAGNETIC CAPTURE AND DETECTION OF INGERABLE EVENT MARKERS |
US10420473B2 (en) | 2016-07-29 | 2019-09-24 | VivaLnk, Inc. | Wearable thermometer patch for correct measurement of human skin temperature |
US10447347B2 (en) | 2016-08-12 | 2019-10-15 | Mc10, Inc. | Wireless charger and high speed data off-loader |
JP2019535377A (ja) | 2016-10-26 | 2019-12-12 | プロテウス デジタル ヘルス, インコーポレイテッド | 摂取可能なイベントマーカを有するカプセルの製造方法 |
US20200054252A1 (en) * | 2016-11-08 | 2020-02-20 | Jsr Corporation | Enzyme sensor and enzyme sensor system |
US10111618B2 (en) | 2017-03-13 | 2018-10-30 | VivaLnk, Inc. | Dual purpose wearable patch for measurement and treatment |
US10321872B2 (en) | 2017-03-13 | 2019-06-18 | VivaLnk, Inc. | Multi-purpose wearable patch for measurement and treatment |
WO2018175489A1 (en) | 2017-03-21 | 2018-09-27 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
USD853583S1 (en) | 2017-03-29 | 2019-07-09 | Becton, Dickinson And Company | Hand-held device housing |
US11766550B2 (en) | 2017-05-21 | 2023-09-26 | Veris Health, Inc. | Implantable medication infusion port with physiologic monitoring |
US11331019B2 (en) | 2017-08-07 | 2022-05-17 | The Research Foundation For The State University Of New York | Nanoparticle sensor having a nanofibrous membrane scaffold |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US20190120785A1 (en) | 2017-10-24 | 2019-04-25 | Dexcom, Inc. | Pre-connected analyte sensors |
EP3485801A1 (en) * | 2017-11-19 | 2019-05-22 | Indigo Diabetes N.V. | Implantable integrated sensor device |
US10080524B1 (en) | 2017-12-08 | 2018-09-25 | VivaLnk, Inc. | Wearable thermometer patch comprising a temperature sensor array |
AU2019206449B2 (en) | 2018-01-11 | 2021-05-06 | Shell Internationale Research Maatschappij B.V. | Wireless reactor monitoring system using passive sensor enabled RFID tag |
CN111557008B (zh) | 2018-01-11 | 2023-11-17 | 国际壳牌研究有限公司 | 使用多个具备传感器功能的rfid标签和多个收发器对反应器条件进行无线检测和分析 |
PL3738319T3 (pl) * | 2018-01-11 | 2023-08-14 | Shell Internationale Research Maatschappij B.V. | Bezprzewodowe monitorowanie i profilowanie warunków reaktora z zastosowaniem układów znaczników RFID zintegrowanych z czujnikiem umieszczonych na znanych wysokościach reaktora |
US10360419B1 (en) | 2018-01-15 | 2019-07-23 | Universal City Studios Llc | Interactive systems and methods with tracking devices |
US11109765B2 (en) | 2018-08-20 | 2021-09-07 | VivaLnk, Inc. | Wearable thermometer patch comprising a temperature sensor array |
US11285482B2 (en) | 2018-09-21 | 2022-03-29 | Lockheed Martin Corporation | Molecular sensing device |
RU2700688C1 (ru) | 2018-09-24 | 2019-09-19 | Самсунг Электроникс Ко., Лтд. | Способы калибровки каналов фазированной антенной решетки |
GB201818696D0 (en) * | 2018-11-15 | 2019-01-02 | Smiths Medical International Ltd | Medico-surgical tubes |
US11096582B2 (en) | 2018-11-20 | 2021-08-24 | Veris Health Inc. | Vascular access devices, systems, and methods for monitoring patient health |
WO2020142454A1 (en) | 2018-12-31 | 2020-07-09 | Chf Solutions, Inc. | Blood flow assisting portable arm support |
US11464908B2 (en) | 2019-02-18 | 2022-10-11 | Tandem Diabetes Care, Inc. | Methods and apparatus for monitoring infusion sites for ambulatory infusion pumps |
US20220218240A1 (en) * | 2019-08-19 | 2022-07-14 | Medtrum Technologies Inc. | Sensing device |
US11565044B2 (en) | 2019-09-12 | 2023-01-31 | Medtronic Minimed, Inc. | Manufacturing controls for sensor calibration using fabrication measurements |
EP4029031A1 (en) * | 2019-09-12 | 2022-07-20 | Medtronic MiniMed, Inc. | Manufacturing controls for sensor calibration using fabrication measurements |
US11654235B2 (en) | 2019-09-12 | 2023-05-23 | Medtronic Minimed, Inc. | Sensor calibration using fabrication measurements |
JP2023509450A (ja) * | 2020-01-03 | 2023-03-08 | アボット ダイアベティス ケア インコーポレイテッド | 複数被検物質を検出するためのセンサアレイシステムおよび方法 |
US20220167135A1 (en) * | 2020-11-24 | 2022-05-26 | Ascensia Diabetes Care Holdings Ag | Test sensor systems and methods using the same |
US11726054B2 (en) * | 2020-11-24 | 2023-08-15 | Ascensia Diabetes Care Holdings Ag | NFC-enabled test sensors, systems and methods using the same |
CN115856273A (zh) * | 2021-09-24 | 2023-03-28 | 深圳硅基传感科技有限公司 | 分析物传感组件的校准方法与校准系统 |
CN115236151A (zh) * | 2022-07-05 | 2022-10-25 | 南京理工大学 | 一种便携式低成本的尿液尿酸检测系统及方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000055865A (ja) * | 1983-05-05 | 2000-02-25 | Medisense Inc | センサシステムの信号読取り回路に取付ける一回使用の使い捨て電極ストリップ |
JP2002041654A (ja) * | 2000-04-18 | 2002-02-08 | Roche Diagnostics Corp | 契約ベースのバイオセンサーモニターシステムおよびバイオセンサーモニター方法 |
WO2004005908A1 (ja) * | 2002-07-02 | 2004-01-15 | Matsushita Electric Industrial Co., Ltd. | バイオセンサ,バイオセンサチップ及びバイオセンサ装置 |
JP2004139345A (ja) * | 2002-10-17 | 2004-05-13 | Srl Inc | 無線型センサ |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141868A (en) * | 1984-06-13 | 1992-08-25 | Internationale Octrooi Maatschappij "Octropa" Bv | Device for use in chemical test procedures |
US4935346A (en) * | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
EP0359831B2 (en) * | 1988-03-31 | 2007-06-20 | Matsushita Electric Industrial Co., Ltd. | Biosensor and process for its production |
US5101814A (en) * | 1989-08-11 | 1992-04-07 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
US5342789A (en) * | 1989-12-14 | 1994-08-30 | Sensor Technologies, Inc. | Method and device for detecting and quantifying glucose in body fluids |
US6040194A (en) * | 1989-12-14 | 2000-03-21 | Sensor Technologies, Inc. | Methods and device for detecting and quantifying substances in body fluids |
DE69020908T2 (de) * | 1989-12-15 | 1996-02-15 | Boehringer Mannheim Corp., Indianapolis, Ind. | Redox-vermittlungs-reagenz und biosensor. |
US5286362A (en) * | 1990-02-03 | 1994-02-15 | Boehringer Mannheim Gmbh | Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor |
GR1002549B (el) * | 1992-05-12 | 1997-01-28 | Lifescan Inc. | Λωρις εξετασεως με μεταφορικο μεσο δια μεταφορα ρευστου. |
CA2079192C (en) * | 1992-09-25 | 1995-12-26 | Bernard Strong | Combined lancet and multi-function cap and lancet injector for use therewith |
US5437999A (en) * | 1994-02-22 | 1995-08-01 | Boehringer Mannheim Corporation | Electrochemical sensor |
PT779984E (pt) * | 1994-09-08 | 2002-03-28 | Lifescan Inc | Tira de leitura optica com padrao integrado para deteccao de um analito |
US5628310A (en) * | 1995-05-19 | 1997-05-13 | Joseph R. Lakowicz | Method and apparatus to perform trans-cutaneous analyte monitoring |
US5879367A (en) * | 1995-09-08 | 1999-03-09 | Integ, Inc. | Enhanced interstitial fluid collection |
JP2000500656A (ja) * | 1995-11-22 | 2000-01-25 | ミニメッド インコーポレイティド | 化学的増幅及び光学センサーを用いる生物分子の検出 |
US5989917A (en) | 1996-02-13 | 1999-11-23 | Selfcare, Inc. | Glucose monitor and test strip containers for use in same |
WO1998055869A1 (en) * | 1997-06-04 | 1998-12-10 | Sensor Technologies, Inc. | Method and device for detecting or quantifying carbohydrate containing compounds |
US6558320B1 (en) * | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
US6217744B1 (en) * | 1998-12-18 | 2001-04-17 | Peter Crosby | Devices for testing fluid |
AU768000B2 (en) * | 1999-02-04 | 2003-11-27 | Integ, Inc. | Needle for body fluid tester |
US6702791B1 (en) * | 1999-02-04 | 2004-03-09 | Integ, Inc. | Needle for body fluid tester |
US6285899B1 (en) * | 1999-02-18 | 2001-09-04 | Motorola, Inc. | Remotely interrogated biomedical sensor |
US6706159B2 (en) * | 2000-03-02 | 2004-03-16 | Diabetes Diagnostics | Combined lancet and electrochemical analyte-testing apparatus |
CN1283806C (zh) * | 2000-03-28 | 2006-11-08 | 糖尿病诊断公司 | 为制造可配置电化学传感器的连续过程 |
CN1280640C (zh) * | 2000-06-05 | 2006-10-18 | Tc许可有限公司 | 确定调制的反向散射通信系统中应答器方向的方法和设备 |
US6961285B2 (en) * | 2000-07-07 | 2005-11-01 | Ddms Holdings L.L.C. | Drug delivery management system |
US20050101841A9 (en) * | 2001-12-04 | 2005-05-12 | Kimberly-Clark Worldwide, Inc. | Healthcare networks with biosensors |
DE10237602A1 (de) | 2002-08-16 | 2004-03-18 | I.E.M. Industrielle Entwicklung Medizintechnik Und Vertriebsgesellschaft Mbh | Glucosemessgerät |
PL1642124T3 (pl) * | 2003-06-20 | 2018-04-30 | F.Hoffmann-La Roche Ag | Biosensory elektrochemiczne |
PL2843848T3 (pl) * | 2004-01-27 | 2018-04-30 | Altivera L L C | Diagnostyczne czujniki identyfikacji radiowej i ich zastosowanie |
-
2005
- 2005-08-31 WO PCT/US2005/031286 patent/WO2006026748A1/en active Application Filing
- 2005-08-31 US US11/574,346 patent/US20070270672A1/en not_active Abandoned
- 2005-08-31 EP EP05795539A patent/EP1794585A1/en not_active Withdrawn
- 2005-08-31 US US11/574,336 patent/US20080114228A1/en not_active Abandoned
- 2005-08-31 CN CNA2005800373701A patent/CN101091114A/zh active Pending
- 2005-08-31 WO PCT/US2005/031271 patent/WO2006026741A1/en active Application Filing
- 2005-08-31 JP JP2007530391A patent/JP5032321B2/ja not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000055865A (ja) * | 1983-05-05 | 2000-02-25 | Medisense Inc | センサシステムの信号読取り回路に取付ける一回使用の使い捨て電極ストリップ |
JP2002041654A (ja) * | 2000-04-18 | 2002-02-08 | Roche Diagnostics Corp | 契約ベースのバイオセンサーモニターシステムおよびバイオセンサーモニター方法 |
WO2004005908A1 (ja) * | 2002-07-02 | 2004-01-15 | Matsushita Electric Industrial Co., Ltd. | バイオセンサ,バイオセンサチップ及びバイオセンサ装置 |
JP2004139345A (ja) * | 2002-10-17 | 2004-05-13 | Srl Inc | 無線型センサ |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010525371A (ja) * | 2007-04-27 | 2010-07-22 | アボット ダイアベティス ケア インコーポレイテッド | 較正のないアナライトセンサおよび方法 |
JP2011528460A (ja) * | 2008-07-17 | 2011-11-17 | ユニバーサル バイオセンサーズ ピーティーワイ リミテッド | 色コード化領域による自動情報転送 |
JP2012504233A (ja) * | 2008-09-30 | 2012-02-16 | メナイ メディカル テクノロジーズ リミテッド | サンプル測定システム |
JP2010107512A (ja) * | 2008-10-30 | 2010-05-13 | Lifescan Scotland Ltd | 最小充填ミス試料観察窓を有する分析テストストリップ |
JP2012509482A (ja) * | 2008-11-20 | 2012-04-19 | アボット・ラボラトリーズ | 自動検査室用分析器において無線識別によってベッセルを追跡するためのシステム |
JP2012529045A (ja) * | 2009-06-04 | 2012-11-15 | イントレスコ・ベスローテン・フェンノートシャップ | Rfidチップでタグ付与されたインレーを備えたシステムを用いて、生物組織サンプルカセットを追跡可能なデバイスに転換する方法 |
JP2014500953A (ja) * | 2010-11-15 | 2014-01-16 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | ガイド付きの体系的な検査キット |
JP2016502088A (ja) * | 2012-12-04 | 2016-01-21 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | ヘマトクリットを補正する方法およびそのために適合させた血糖測定器 |
Also Published As
Publication number | Publication date |
---|---|
EP1794585A1 (en) | 2007-06-13 |
US20080114228A1 (en) | 2008-05-15 |
WO2006026748A1 (en) | 2006-03-09 |
US20070270672A1 (en) | 2007-11-22 |
WO2006026741A1 (en) | 2006-03-09 |
JP5032321B2 (ja) | 2012-09-26 |
CN101091114A (zh) | 2007-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5032321B2 (ja) | 自動較正センサの製造方法 | |
JP5210871B2 (ja) | ストリップコーディング機能を有する測定器一体型のテストストリップ容器 | |
US20100068093A1 (en) | Identification of a Strip Type by the Meter Using Conductive Patterns on the Strip | |
EP2426485B1 (en) | Method of making biosensors | |
EP0636880B1 (en) | Quantitative analyzing apparatus | |
EP1678496B1 (en) | Meter and test sensor bank incorporating re-writable memory | |
US7988917B2 (en) | Analytical test element with wireless data transmission | |
JP5074193B2 (ja) | 定量的測定および定性的測定のための使い捨て式自己充足型検定装置 | |
JP5726286B2 (ja) | 自己完結型の体外診断装置 | |
US7875240B2 (en) | Auto-calibration label and method of forming the same | |
US20080133059A1 (en) | Table-driven test sequence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080728 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110128 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110607 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110720 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120125 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120605 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120628 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5032321 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150706 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |